Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 16))

Abstract

Numerous papers have suggested that decreased thyroid function would ameliorate or slow the development of experimental hypertension. In addition, a number of papers have documented decrease in one parameter or another of thyroid function in various types of experimental hypertension. The clinical literature has suggested that hypothyroidism may be associated with hypertension which certainly would not be anticipated from the animal studies. There is relatively little about any causal role of hyperthyroidism in the development of diastolic hypertension in humans. This article will first review the clinical literature on hypothyroidism and hyperthyroidism and then discuss the experimental literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thompson WO, Dickie LFN, Morris HE, Hilkevitch BH: The high incidence of hypertension in toxic goiter and in mycedema. Endocrinology 15: 265–272, 1931.

    Article  Google Scholar 

  2. Endo T, Komiya I, Tsukui T, Yamada T, Izumiyama T, Nagata H, Kono S, Kamata K: Re-evaluation of a high possible incidence of hypertension in hypothyroid patients. Am Heart J 98: 684–688, 1979.

    Article  PubMed  CAS  Google Scholar 

  3. Boone G, Langford HG: Effect of propylthiouracil and 13I on blood pressures of thyrotoxic patients: A retrospective study. S Afr Med J 60: 24–25, 1967.

    CAS  Google Scholar 

  4. Fregly MJ: Modification of thyroid activity during development of experimental renal hypertension in rats. Texas Reports in Biology and Medicine. 29: 63–73, 1971.

    CAS  Google Scholar 

  5. Koizuma Y, Aizawa T, Tawata M, Yamata T, Yamori Y, Okomoto K: Effect of normalization of hypometabolic state on blood pressure in spontaneously hypertensive rats and in patients with essential hypertension. J Am Gen Soc XXIV: 454–457, 1976.

    Google Scholar 

  6. Salgado E, Green DM: Mechanisms of desoxycorticosterone action XII. Influence of the thyroid. Am J Physiol. 188: 519–523, 1957.

    PubMed  CAS  Google Scholar 

  7. Green DM, Saunders FJ, Wahlgreen N, Craig RL: Self-sustaining, post-DCA hypertensive cardiovascular disease. AM J Physiol. 170: 94, 1952.

    PubMed  CAS  Google Scholar 

  8. Landsberg L: Catecholamines and the sympathoadrenal system. In: The Thyroid 5th edn., pp. 791–800. Werner SC, Ingbar SH, eds. New York: Harper & Row, 1978.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Langford, H.G. (1982). Hypertension Secondary to Thyroid Dysfunction. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_37

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7476-0_37

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7478-4

  • Online ISBN: 978-94-009-7476-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics